di Filippo, Luigi
Terenzi, Umberto
Di Ienno, Giovanni
Trasciatti, Silvia
Bonaretti, Silvano
Giustina, Andrea
Article History
Received: 12 April 2024
Accepted: 28 May 2024
First Online: 10 June 2024
Change Date: 27 June 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s12020-024-03939-5
Conflict of interest
: A.G. is consultant for Abiogen Pharma S.p.A. and Takeda and received research grant to Institution from Takeda. L.d.F. received research grants to Institution from Abiogen Pharma S.p.A. All other authors have no conflict of interest to declare.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study protocol was approved by the Hospital Ethics Committee (protocol ABIO/NC/03 no. 367/2020).
: Signed informed consent was obtained from all individuals participating in this study.